News Focus
News Focus
Followers 63
Posts 5557
Boards Moderated 0
Alias Born 01/17/2005

Re: iwfal post# 3627

Tuesday, 03/04/2008 1:17:14 PM

Tuesday, March 04, 2008 1:17:14 PM

Post# of 8473
<If a trial gets a p value of x (lets go with 0.04), what is the chance that it is an efficacious drug?>

How often does this happen in a Phase 2 ? With any registerable endpoints ??

Perhaps you need to criticise the industry, not for bad Phase 3 design, but for bad Phase 2 design.

"....on the biotech battle-field, you need some élan...."

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RPRX News